Endophthalmitis following intravitreal injection of anti-VEGF agents: long-term outcomes and the identification of unusual micro-organisms

BACKGROUND: While the development of targeted molecular therapy to inhibit vascular endothelial growth factor (VEGF) has revolutionized the treatment and visual prognosis of highly prevalent retinal diseases such as diabetic retinopathy and age-related macular degeneration, each intravitreal injecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sachdeva, Mira M., Moshiri, Ala, Leder, Henry A., Scott, Adrienne W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710619/
https://www.ncbi.nlm.nih.gov/pubmed/26758203
http://dx.doi.org/10.1186/s12348-015-0069-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710619/
https://www.ncbi.nlm.nih.gov/pubmed/26758203
http://dx.doi.org/10.1186/s12348-015-0069-5

Ejemplares similares